Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.94 EUR | -3.14% | -2.18% | -5.73% |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Sales forecast by analysts have been recently revised upwards.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Low profitability weakens the company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-5.73% | 95.25M | - | ||
-14.45% | 85.02B | B- | ||
+14.42% | 82.37B | C+ | ||
+9.37% | 29.29B | C+ | ||
-10.34% | 17.21B | B | ||
-0.36% | 16.7B | A- | ||
+1.05% | 15.5B | A- | ||
+4.32% | 12.15B | A- | ||
-2.34% | 12.13B | A- | ||
+31.80% | 12.12B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- V3V Stock
- Ratings VITA 34 AG